Ukuqonda izinselele zeSifo Sezinso Ezingamahlalakhona:
I-Chronic Kidney Disease (CKD) inselele yezempilo yomhlaba wonke, ngokuvamile iqhubekela phambili buthule ekuhlulekeni kwezinso futhi idinga ukwelashwa okushintsha ukuphila okufana ne-dialysis noma ukufakelwa kabusha. Ngaphambi kokufinyelela kulezi zigaba, abantu abaningi abane-CKD baba nezinkinga ezinzima zenhliziyo, okuhlanganisa ukuhluleka kwenhliziyo, i-acute myocardial infarction, kanye nokushaywa unhlangothi.
Ukuba yinkimbinkimbi Ekulawuleni Izifo Ezingamahlalakhona Zezinso:
Ukuphathwa kwe-CKD kuba nzima nakakhulu ukuhlalisana kwayo nezimo eziningi ezihambisanayo ezifana nesifo sikashukela, umfutho wegazi ophakeme, ukukhuluphala ngokweqile, izifo zenhliziyo nemithambo yegazi, nokunye. Lokhu multimorbidity kwenza ukuphathwa kwe-CKD kube nzima, kube yinselele, futhi kuvame ukukhungathekisa ochwepheshe bezempilo neziguli ngokufanayo.
I-NephKare iyithuluzi ledijithali lokwenza ukunakekelwa kwezinso kube lula kochwepheshe bezokunakekelwa kwempilo. Kulula ukuyisebenzisa futhi Imahhala ukulanda Uhlelo lokusebenza
Uhlelo lokusebenza lusebenzisa ubuchwepheshe ukusiza ukuphatha i-CKD ngokuhambisana nezifo ezivamile ezifana nesifo sikashukela, umfutho wegazi ophakeme, ukukhuluphala, kanye nezifo zenhliziyo nemithambo yegazi. Le ndlela edidiyelwe ibalulekile, njengoba iningi leziguli ezine-CKD libhekene nengozi yokwehluleka kwenhliziyo, i-acute myocardial infarction, kanye nokushaywa unhlangothi ngaphambi kokudlulela ekuhlulekeni kwezinso.
I-NephKare yenza ukuphatha okusekelwe kumhlahlandlela kungeneke kakhudlwana futhi kusebenze Ochwepheshe Bokunakekelwa Kwezempilo. Uhlelo lokusebenza luhlanganisa izici ongazisekela usebenzisa imithi efakazelwe, ephumelelayo, nengabizi. Lokhu kufaka phakathi i-SGLT-2 inhibitors, i-Metformin, i-GLP-1 receptor agonists, i-ACEi/ARBs, i-nsMRA, i-Statins, nama-Antiplatelet agents—zonke ezaziwa ngomthelela wazo obalulekile ekuthuthukiseni imiphumela yezinso nenhliziyo.
Eminingi yale mithi ebalulekile ayisebenzi nje kuphela kodwa futhi itholakala kabanzi futhi iyathengeka, okwenza ifinyeleleke kubantu abaningi. I-NephKare isiza ochwepheshe bezokunakekelwa kwempilo ekusebenziseni kahle le mithi ukunciphisa ukuqhubeka kwe-CKD kanye nezingozi zayo zenhliziyo nemithambo yegazi.
Khetha i-NephKare ukuze uthole indlela ehleleke kakhudlwana, ephumelelayo, nephumelelayo yokulawula Isifo Sezinso Esingapheli emsebenzini wakho. “Asibambene ngezandla ekuguquleni ukunakekelwa kwempilo yezinso nokwenza ngcono imiphumela yezigidi zeziguli emhlabeni jikelele.”
Kungani i-NephKare?
Ukubhekana Nesimo Esihlukahlukene Se-CKD: I-CKD ivame ukuhlangana nesifo sikashukela, umfutho wegazi ophakeme, ukukhuluphala, kanye nezifo zenhliziyo, okuveza inselele yokuphatha eyinkimbinkimbi ekunakekelweni okuyinhloko.
Ukuvala Izikhala Zolwazi: Ochwepheshe bokunakekelwa okuyisisekelo bavame ukubhekana nokudideka nokungaguquguquki ekuphathweni kwe-CKD, okuholela emiphumeleni engafanele yesiguli.
Ukunikeza Amandla Ngokunakekelwa Okusekelwe Ebufakazini: I-NephKare iletha amandla okunakekelwa kwezinso okusekelwe kumhlahlandlela we-KDIGO phambili, yenza kube lula ukuxilongwa kusenesikhathi nokungenelela okuphumelelayo.
Izici ezibalulekile ze-NephKare:
1. Ukuphatha Okuphelele
2. Ukutholwa Kusenesikhathi Nokuxilongwa
3. Ukwelashwa Okusekelwe Kumhlahlandlela
4. Ukuhlanganisa Ukwelapha Okuthuthukile
5. Isixhumi esibonakalayo Esisebenziseka kalula
6. Idatha Yesikhathi Sangempela Nezibalo
Ubani Ongazuza?
Ama-Nephrologists, Odokotela, Odokotela Jikelele, Odokotela Besifo Sikashukela, Odokotela Benhliziyo. Abanye ochwepheshe bezempilo ababambe iqhaza ekuphathweni kwe-CKD
Joyina I-Fight Against CKD:
Nge-NephKare, ngena enkathini entsha yokunakekelwa kwezinso futhi uguqule indlela osiphatha ngayo isifo sezinso. Landa manje futhi uphakamise ukwenza kwakho ngamandla empilo yedijithali.
Xhumana nathi:
UDkt Chinta Rama Krishna MD, DM
I-Secretory Andhra Pradesh Society of Nephrology
Umsunguli-HelloKidney.ai
Ukuze uthole olunye ulwazi, sicela uvakashele ku-www.hellokidney.ai noma usithinte ku- +919701504777
Kubuyekezwe ngo-
Nov 15, 2025